191 related articles for article (PubMed ID: 12685518)
1. Longer term effects of stimulant treatments for Attention-Deficit/Hyperactivity Disorder.
Jensen P
J Atten Disord; 2002; 6 Suppl 1():S45-56. PubMed ID: 12685518
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder.
Biederman J; Spencer T
J Atten Disord; 2002; 6 Suppl 1():S101-7. PubMed ID: 12685524
[TBL] [Abstract][Full Text] [Related]
3. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
4. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study.
Ricketts EJ; Sturm A; McMakin DL; McGuire JF; Tan PZ; Smalberg FB; McCracken JT; Colwell CS; Piacentini J
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):690-698. PubMed ID: 30388029
[No Abstract] [Full Text] [Related]
5. Treatment of attention-deficit/hyperactivity disorder.
Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
[TBL] [Abstract][Full Text] [Related]
6. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Dev Behav Pediatr; 2006 Feb; 27(1):1-10. PubMed ID: 16511362
[TBL] [Abstract][Full Text] [Related]
7. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
Arch Gen Psychiatry; 1999 Dec; 56(12):1073-86. PubMed ID: 10591283
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.
Rösler M; Retz W; Fischer R; Ose C; Alm B; Deckert J; Philipsen A; Herpertz S; Ammer R
World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312
[TBL] [Abstract][Full Text] [Related]
9. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
10. Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder.
Setyawan J; Yang H; Cheng D; Cai X; Signorovitch J; Xie J; Erder MH
Value Health; 2015 Sep; 18(6):824-31. PubMed ID: 26409610
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
13. 12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.
Hoare P; Remschmidt H; Medori R; Ettrich C; Rothenberger A; Santosh P; Schmit M; Spender Q; Tamhne R; Thompson M; Tinline C; Trott GE
Eur Child Adolesc Psychiatry; 2005 Sep; 14(6):305-9. PubMed ID: 16220214
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
15. An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
Groenman AP; Schweren LJ; Dietrich A; Hoekstra PJ
Expert Opin Drug Saf; 2017 Apr; 16(4):455-464. PubMed ID: 28277842
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
Moungnoi P; Maipang P
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
[TBL] [Abstract][Full Text] [Related]
17. Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.
Rapoport JL; Inoff-Germain G
J Atten Disord; 2002; 6 Suppl 1():S57-60. PubMed ID: 12685519
[TBL] [Abstract][Full Text] [Related]
18. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
19. High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler.
Lipkin PH; Butz AM; Cozen MA
J Child Adolesc Psychopharmacol; 2003; 13(1):103-6. PubMed ID: 12804131
[TBL] [Abstract][Full Text] [Related]
20. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.
Greenhill LL; Abikoff HB; Arnold LE; Cantwell DP; Conners CK; Elliott G; Hechtman L; Hinshaw SP; Hoza B; Jensen PS; March JS; Newcorn J; Pelham WE; Severe JB; Swanson JM; Vitiello B; Wells K
J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1304-13. PubMed ID: 8885584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
